Govt Job for Project Research Associate at RCB, Govt of India

Regional Centre for Biotechnology (RCB), an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO.

The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu.

Post : Project Research Associate-I

Title of Project : ”Elucidation of the functional interactome of legumes with the fungal pathogen Erysiphe pisi as keys to powdery mildew disease resistance”. (The Project involves extensive protein purification, biochemical and biophysical characterization and structural studies).

Duration : Initially for one year, extendable on annual evaluation.
Age Limit : 37 Years

Essential Qualifications : PhD in Life Sciences. Minimum 60% marks in Masters or equivalent degree. Demonstrated experience (Substantiated by first author publication) in protein purification, crystallization and protein structure determination.

Desirable Qualifications : Experience in molecular biology techniques, biochemical and biophysical techniques, good oral and written communication skills and ability to work independently are preferred.

Fellowship :Rs. 47,000/- + 16% HRA per month.
Principal Investigator (PI) : Dr. Divya Chandran, Associate Professor; Co-PI: Dr. Deepti Jain, Associate Professor (The position will be in Dr. Deepti’s lab)

The shortlisted candidates will be informed by 20th March, 2021 via email to appear in the online interview to be held at 11:00 AM onwards on 22nd March, 2021. Candidates who applied previously to the same post in the same project, need not apply again.

Regional Centre for Biotechnology,
3rd Milestone, Faridabad-Gurgaon Expressway
NCR Biotech Science Cluster, Faridabad,
Faridabad (Haryana).

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework